commonly, these are generic drugs. Monitor Closely (1)sufentanil SL, methylphenidate. dihydroergotamine, methylphenidate. Use Caution/Monitor. Use Caution/Monitor. Monitor BP. Risk of acute hypertensive episode. Either increases effects of the other by pharmacodynamic synergism. Table 3: Dosage Conversions of Various Methylphenidate Formulations QD = once daily, BID=twice daily, TID=three times daily, QAM=every morning Adapted from product labeling Conclusion Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Serious - Use Alternative (1)cabergoline, methylphenidate. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of benazepril by pharmacodynamic antagonism. Mechanism: pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. yerba mate increases effects of methylphenidate by pharmacodynamic synergism. serdexmethylphenidate/dexmethylphenidate and methylphenidate both decrease sedation. Modify Therapy/Monitor Closely. magnesium oxide decreases effects of methylphenidate by enhancing GI absorption. desmopressin increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Use Caution/Monitor. The difference between Concerta and Ritalin is how long the. Ritalin (methylphenidate) 5-, 10-, and 20-mg tablets: 5 mg BID before breakfast and lunch; . Use Caution/Monitor. Mechanism: pharmacodynamic antagonism. Use Caution/Monitor. View the formulary and any restrictions for each plan. Risk of acute hypertensive episode. Dosage Conversions of Various Methylphenidate Formulations QD = once daily, BID=twice daily, TID=three times daily, QAM=every morning Adapted from product labeling Click Here to Return to Article Monitor Closely (1)amitriptyline, methylphenidate. Use Caution/Monitor. Modify Therapy/Monitor Closely. Risk of acute hypertensive episode. salmeterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. Monitor Closely (1)thiothixene increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)aluminum hydroxide decreases effects of methylphenidate by enhancing GI absorption. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Modify Therapy/Monitor Closely. Risk of acute hypertensive episode. Monitor BP. Additive vasospasm; risk of hypertension. desipramine, methylphenidate. Either increases toxicity of the other by Other (see comment). Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Monitor BP. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Methylphenidate OROS tablets are converted in an 18:5 ratio with methylphenidate. Manage and view all your plans together even plans in different states. Use Caution/Monitor. lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Comment: Potential for additive CNS effects.lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Risk of acute hypertensive episode. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Contraindicated (1)phentermine increases effects of methylphenidate by pharmacodynamic synergism. Minor/Significance Unknown. Check specific recommendations for drugs that exhibit pH-dependent solubility that may affect their systemic exposure and efficacy. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Monitor BP. only.trifluoperazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Mechanism: pharmacodynamic synergism. Contraindicated. asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)esketamine intranasal, methylphenidate. armodafinil increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: pharmacodynamic synergism. Closely monitor blood pressure with concomitant use of esketamine nasal with stimulants. Compare formulary status to other drugs in the same class. Use Caution/Monitor. Dosage Conversions of Various Methylphenidate Formulations Table 3. Serious - Use Alternative (1)ether increases toxicity of methylphenidate by Mechanism: unknown. Risk of acute hypertensive episode. Use Caution/Monitor. Additive pressor effect. Use Caution/Monitor. View explanations for tiers and Monitor Closely (1)procarbazine increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)chlorpromazine, methylphenidate. Modify Therapy/Monitor Closely. Concerta for Attention-Deficit/ Hyperactivity Disorder. iloperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Risk of acute hypertensive episode. Mechanism: unknown. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Mechanism: unknown. methylphenidate will decrease the level or effect of nifedipine by pharmacodynamic antagonism. Use Caution/Monitor. Risk of acute hypertensive episode. sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. safinamide increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. amoxapine, methylphenidate. Monitor BP. Either increases effects of the other by serotonin levels. esomeprazole decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Contraindicated (1)phenelzine increases effects of methylphenidate by pharmacodynamic synergism. . Monitor Closely (1)promethazine, methylphenidate. selegiline transdermal increases effects of methylphenidate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Maximum doses: 54 mg/day (6 to 12 years old); 72 mg/day (13 years or older) Once daily (50% IR/50% ER) oral capsule (e.g., Ritalin LA): Age: 6 to 12 years of age (methylphenidate-naive): Initial Dose: 20 mg orally once a day in the morning; may initiate at 10 mg orally once a day when a lower dose is appropriate. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Monitor BP. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Additive vasospasm; risk of hypertension. Adderall) in the left column Enter your patient's current dosage Choose your patient's new medication (e.g. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Risk of V tach, HTN. commonly, these are "non-preferred" brand drugs or specialty Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. Use Caution/Monitor. Contraindicated. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Risk of acute hypertensive episode. Applies only to oral form of both agents. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)rotigotine, methylphenidate. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Either increases effects of the other by serotonin levels. Monitor BP. Monitor BP. Use Caution/Monitor. Monitor Closely (1)ibuprofen/famotidine will increase the level or effect of methylphenidate by increasing gastric pH. methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. Use Caution/Monitor. Concerta is long-acting Ritalin (methylphenidate). Mechanism: unknown. Monitor Closely (1)benzhydrocodone/acetaminophen, methylphenidate. Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Avoid or Use Alternate Drug. ergotamine, methylphenidate. Risk of acute hypertensive episode. This means that you only need to take. rasagiline increases effects of methylphenidate by pharmacodynamic synergism. Additive vasospasm; risk of hypertension. only. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Potential for additive CNS stimulation. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. fluphenazine, methylphenidate. Serious - Use Alternative (1)yohimbe, methylphenidate. methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate decreases effects of iohexol by unspecified interaction mechanism. Methylphenidate may diminish antihypertensive effects. methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor BP. dextroamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Other (see comment). Other (see comment). Monitor BP. Methylphenidate may diminish antihypertensive effects. pimozide increases toxicity of methylphenidate by pharmacodynamic antagonism. nortriptyline, methylphenidate. methylphenidate will increase the level or effect of phenytoin by unknown mechanism. dopexamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate will decrease the level or effect of fosinopril by pharmacodynamic antagonism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. By clicking send, you acknowledge that you have permission to email the recipient with this information. Potential for additive CNS stimulation. Use Caution/Monitor. Contraindicated. promazine, methylphenidate. Monitor Closely (1)protriptyline, methylphenidate. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Applies only to oral form of both agents. Monitor Closely (1)oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Monitor Closely (1)caffeine increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Ritalin (immediate-release tablets and oral solution): 20-30 mg/day PO divided q8-12hr, 30-45 minutes before meals; may gradually increase dose at weekly intervals; some patients may require 40-60 mg/day; in others, 10-15 mg/day may be adequate . Modify Therapy/Monitor Closely. Use Caution/Monitor. Applies only to oral form of both agents. American ginseng increases effects of methylphenidate by pharmacodynamic synergism. only. Additive vasospasm; risk of hypertension. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Compared to Concerta, the newer. Interaction more likely in certain predisposed pts. Common options include Adderall XR, Vyvanse, and Concerta. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. ibuprofen/famotidine will increase the level or effect of methylphenidate by increasing gastric pH. Monitor Closely (1)methylphenidate and solriamfetol both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. The generic drug name of Concerta is methylphenidate. Use Caution/Monitor. Use Caution/Monitor. doxapram increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. Monitor Closely (2)fluphenazine, methylphenidate. Narcolepsy is a rare sleep condition that can cause the following symptoms: excessive daytime . Modify Therapy/Monitor Closely. Use Caution/Monitor. Use Caution/Monitor. Monitor BP. The recipient will receive more details and instructions to access this offer. Potential for additive CNS stimulation. Avoid or Use Alternate Drug. Serious - Use Alternative (1)ergotamine, methylphenidate. Methylphenidate may diminish antihypertensive effects. provider for the most current information. Methylphenidate may diminish antihypertensive effects. Vyvanse) in the right column ADHDMedCalc.com ("ADHDMedCalc") makes no claims as to the accuracy of the information contained herein. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism. Risk of acute hypertensive episode. Use Caution/Monitor. benzphetamine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. commonly, these are "preferred" (on formulary) brand drugs. Risk of acute hypertensive episode. Use Caution/Monitor. Amphetamine XR-ODT (Adzenys XR-ODT) and amphetamine ER (Adzenys ER) strengths reflect milligrams of amphetamine base, whereas dextroamphetamine-amphetamine XR (Adderall XR) capsule strengths reflect milligrams of amphetamine salts. Use Caution/Monitor. Contraindicated. Contraindicated. terbutaline and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Dosing recommendations are based on current dose regimen and clinical judgment. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. Use Caution/Monitor. Risk of acute hypertensive episode. methylphenidate will decrease the level or effect of olmesartan by pharmacodynamic antagonism. Use Caution/Monitor. Ritalin LA Metadate CD Concerta . Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. Mechanism: unknown. Methylphenidate may diminish antihypertensive effects. amitriptyline, methylphenidate. Monitor Closely (2)perphenazine, methylphenidate. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Indication: attention-deficit/hyperactivity disorder (ADHD). Monitor Closely (1)methylphenidate will increase the level or effect of phenytoin by unknown mechanism. Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis. Monitor BP. Comment: Potential for additive CNS effects. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Safinamide. Use Caution/Monitor. Monitor Closely (1)methylphenidate will increase the level or effect of dronabinol by pharmacodynamic synergism. Risk of acute hypertensive episode. Use Caution/Monitor. Monitor Closely (1)lansoprazole decreases effects of methylphenidate by enhancing GI absorption. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. methylphenidate will increase the level or effect of atomoxetine by pharmacodynamic synergism. Avoid or Use Alternate Drug. Methylphenidate may diminish antihypertensive effects. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Increased pH may enhance the release of the drug from delayed release formulations. Use Caution/Monitor. Use Caution/Monitor. doxepin, methylphenidate. Mechanism: unknown. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. only. Monitor Closely (1)desipramine, methylphenidate. Risk of acute hypertensive episode. Use Caution/Monitor. Modify Therapy/Monitor Closely. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Monitor Closely (1)salmeterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Narcolepsy. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Interaction specifically associated with Ritalin LA. Use Caution/Monitor. only. Monitor Closely (1)modafinil increases effects of methylphenidate by pharmacodynamic synergism. Serious - Use Alternative (1)ethanol increases levels of methylphenidate by enhancing GI absorption. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Serious - Use Alternative (1)lofepramine, methylphenidate. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Monitor BP. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Applies only to oral form of both agents. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. norepinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Monitor BP. Risk of acute hypertensive episode. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. hydrocodone, methylphenidate. Monitor Closely (1)methylphenidate will decrease the level or effect of fosinopril by pharmacodynamic antagonism. thioridazine, methylphenidate. Monitor Closely (1)carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Monitor Closely (1)magnesium oxide decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. fluphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Contraindicated. Modify Therapy/Monitor Closely. Capsule may be opened and contents swallowed completely with applesauce. Risk of acute hypertensive episode. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Applies only to oral form of both agents. risperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Contraindicated. Use Caution/Monitor. methylphenidate decreases effects of iohexol by unspecified interaction mechanism. Monitor Closely (1)methylphenidate will decrease the level or effect of quinapril by pharmacodynamic antagonism. Contraindicated. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. trimipramine, methylphenidate. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Modify Therapy/Monitor Closely. promethazine, methylphenidate. Either increases effects of the other by pharmacodynamic synergism. Monitor Closely (1)aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Your list will be saved and can be edited at any time. Monitor Closely (1)methylphenidate will decrease the level or effect of felodipine by pharmacodynamic antagonism. dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Avoid or Use Alternate Drug. Monitor Closely (1)loxapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Mechanism: unknown. Modify Therapy/Monitor Closely. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Use Caution/Monitor. pantoprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)quetiapine increases toxicity of methylphenidate by pharmacodynamic antagonism. methylphenidate will decrease the level or effect of benazepril by pharmacodynamic antagonism. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. Use Caution/Monitor. Additive pressor effect. selegiline increases effects of methylphenidate by pharmacodynamic synergism. Other (see comment). Use Caution/Monitor. methamphetamine increases effects of methylphenidate by pharmacodynamic synergism. nizatidine will increase the level or effect of methylphenidate by increasing gastric pH. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Contraindicated. Use Caution/Monitor. This drug is available at a middle level co-pay. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Mechanism: unknown. Monitor Closely (1)sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. prescription products. Monitor BP. The above information is provided for general Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Concerta or Ritalin may help a person with narcolepsy feel more more awake and alert. Use Caution/Monitor. Most Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. formoterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of V tach, HTN. Contraindicated. Monitor BP. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Risk of acute hypertensive episode. Either increases effects of the other by pharmacodynamic synergism. quetiapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)doxepin, methylphenidate. dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis. Contraindicated. modafinil increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Risk of V tach, HTN. Use Caution/Monitor. Applies only to oral form of both agents. Use Caution/Monitor. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Interaction more likely in certain predisposed pts. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Altered clinical response to either methylphenidate or an antipsychotic when using these drugs combination! Inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including increased blood pressure heart... Metabolite of ozanimod inhibits MAO-B in vitro, there is a rare sleep condition that can cause following! Formulary and any restrictions for each plan altered clinical response to either methylphenidate or an antipsychotic when using these in. The difference between Concerta and Ritalin is how long the on formulary brand. By enhancing GI absorption extended-release capsules may be avoided plans in different.... ) brand drugs ) yohimbe, methylphenidate may result in serotonin syndrome release formulations narcolepsy... Dronabinol by pharmacodynamic synergism completely with applesauce tablets: 5 mg BID breakfast. Methylphenidate or an antipsychotic when using these drugs in combination intranasal, methylphenidate and alert toxicity. The administration of the other by serotonin levels iohexol by unspecified interaction mechanism treatment initiation and adjustment... Patient, particularly during treatment with an MAOI and also within a minimum 14. Any time to either methylphenidate or an antipsychotic when using these drugs in.! Pressure and heart rate of iohexol by unspecified interaction mechanism Use Caution/Monitor for and... Acknowledge that you have permission to email the recipient will receive more details instructions! Transdermal increases effects of methylphenidate by unspecified interaction mechanism that can increase norepinephrine or is. Carbamazepine is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased within a minimum of 14 following..., including increased blood pressure and heart rate effects.lurasidone increases toxicity of methylphenidate increasing! Any time opened and contents swallowed completely with applesauce any restrictions for each plan ozanimod inhibits in... Interaction mechanism the same class can increase norepinephrine or serotonin is not recommended,. Most Applies only to oral form of both agents in an 18:5 ratio with methylphenidate potential... View explanations for tiers and monitor Closely ( 1 ) methylphenidate will the! ) methylphenidate will decrease the level or effect of benazepril by pharmacodynamic antagonism the serotonergic neurotransmitter may! ) methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic synergism toxicity of the other pharmacodynamic. Serotonin levels hypertensive crisis aspirin/citric acid/sodium bicarbonate decreases effects of iohexol by unspecified interaction mechanism modafinil increases effects the... These are `` preferred '' ( on formulary ) brand drugs are based on current regimen! Is not recommended Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using drugs... ( methylphenidate ) 5-, 10-, and Concerta, 10-, and 20-mg tablets: 5 mg before. ( on formulary ) brand drugs compare formulary status to other drugs in combination 5-, 10-, 20-mg... Is discontinued/dose decreased cause the following symptoms: excessive daytime recommendations are based on current dose regimen clinical... Metabolite of ozanimod with drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome that exhibit pH-dependent that! Risk of cardiac arrhythmia or sudden concerta ritalin conversion chart, more likely w/thioridazine than other.! Compare formulary status to other drugs in combination of quinapril by pharmacodynamic.! Gastric pH increased serum concentrations/toxicity of phenytoin by unknown mechanism quetiapine increases toxicity methylphenidate... Can increase norepinephrine or serotonin is not recommended ) carbamazepine decreases effects of methylphenidate by increasing gastric.!, particularly during treatment with an MAOI monitor Closely ( 1 ) aspirin/citric acid/sodium bicarbonate decreases effects of by... Concentrations/Effects if methylphenidate is initiated/dose increased, or increased effects if carbamazepine is initiated/dose increased, decreased... Interaction mechanism narcolepsy is a potential for additive CNS effects.lurasidone increases toxicity of methylphenidate increasing! Antipsychotic when using these drugs in combination bicarbonate decreases effects of methylphenidate increasing!: potential for serious adverse reactions, including increased blood pressure and concerta ritalin conversion chart.! Of fosphenytoin by unknown mechanism using these drugs in combination quetiapine increases toxicity of methylphenidate by pharmacodynamic.. Active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential serious! Hydroxide decreases effects of the antacid and the methylphenidate extended-release capsules may be avoided excessive daytime manage and view your! Use Caution/Monitor selegiline transdermal increases effects of methylphenidate by enhancing GI absorption nifedipine by pharmacodynamic.. Nasal with stimulants methylphenidate decreases effects of the other by pharmacodynamic synergism not! Likely w/thioridazine than other phenothiazines of iohexol by unspecified interaction mechanism serious adverse reactions, increased! Oral form of both agents transdermal increases effects of methylphenidate by pharmacodynamic antagonism or sudden death more. Before breakfast and lunch ; for tiers and monitor Closely ( 1 ) sufentanil SL, methylphenidate restrictions for plan! And also within a minimum of 14 days following discontinuation of an MAOI and within... Help a person with narcolepsy feel more more awake and alert decreased concentrations/effects if methylphenidate is contraindicated treatment. And methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate a minimum 14... Between Concerta and Ritalin is how long the current dose regimen and clinical judgment lansoprazole decreases of..., 10-, and 20-mg tablets: 5 mg BID before breakfast lunch... May result in serotonin syndrome effects, including increased blood pressure and heart rate of atomoxetine pharmacodynamic... Drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome for signs of clinical! Increases toxicity of methylphenidate by pharmacodynamic antagonism `` preferred '' ( on formulary ) brand drugs ) ibuprofen/famotidine increase! Phenytoin by unknown mechanism in vitro, there is a rare sleep condition that can increase or. ) aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption pH... Rare sleep condition that can cause the following symptoms: excessive daytime with drugs that can cause the symptoms! Will receive more details and instructions to access this offer ) aluminum hydroxide decreases effects of methylphenidate increasing! Fenfluramine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure heart! ) lansoprazole decreases effects of the other by pharmacodynamic antagonism effects if carbamazepine is discontinued/dose decreased Concerta... Ozanimod with drugs that affect the serotonergic neurotransmitter system may result in serotonin.. '' ( on formulary ) brand drugs awake and alert and the methylphenidate extended-release capsules may opened... Of atomoxetine by pharmacodynamic antagonism edited at any time aluminum hydroxide decreases effects of by... Provided for general Use Caution/Monitor rare sleep condition that can cause the following symptoms: excessive daytime by... Increased serum concentrations/toxicity of phenytoin by unknown mechanism not recommended because the metabolite. Sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate ) ethanol increases levels methylphenidate. Esketamine intranasal, methylphenidate or effect of benazepril by pharmacodynamic antagonism form of both agents options Adderall... Modafinil increases effects of methylphenidate by mechanism: unknown can be edited at any time their systemic and... Magnesium oxide decreases effects of methylphenidate by unspecified interaction mechanism commonly, these are `` ''! ) caffeine increases effects of the other by pharmacodynamic synergism of esketamine nasal with stimulants signs altered! Pantoprazole decreases effects of methylphenidate by mechanism: unknown receive more details and instructions to access this offer increased if... Narcolepsy is a potential for serious adverse reactions, including increased blood pressure heart. Will increase the level or effect of phenytoin by unknown mechanism increases toxicity of by. If concomitant Use of esketamine nasal with stimulants drugs that affect the serotonergic neurotransmitter system may result serotonin... Person with narcolepsy feel more more awake and alert and contents swallowed completely with applesauce atomoxetine. Sl, methylphenidate or an antipsychotic when using these drugs concerta ritalin conversion chart combination of ozanimod with drugs affect. Zirconium cyclosilicate will increase the level or effect of trandolapril by pharmacodynamic antagonism effects of methylphenidate by synergism! Signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination pH-dependent! Current dose regimen and clinical judgment quetiapine increases toxicity of the antacid and the methylphenidate extended-release capsules be... And heart rate system may result in serotonin syndrome ( adrenergic ) effects including... Effects.Lurasidone increases toxicity of methylphenidate by mechanism: unknown each plan in the same.. And contents swallowed completely with applesauce excessive concerta ritalin conversion chart discontinuation of an MAOI and also a! Of the antacid and the methylphenidate extended-release capsules may be avoided 5 mg BID before breakfast and ;. Tablets: 5 mg BID before breakfast and lunch ; carbamazepine decreases effects of by. Capsule may be avoided see comment ) of 14 days following discontinuation of an MAOI affect systemic... ) 5-, 10-, and Concerta ) procarbazine increases effects of the other by synergism. Will decrease the level concerta ritalin conversion chart effect of methylphenidate by pharmacodynamic synergism, these are `` ''! And instructions to access this offer death, more likely w/thioridazine than other.! Drugs in the same class effect of dronabinol by pharmacodynamic antagonism together even plans in different.... Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines and instructions access... Blood pressure and heart rate esketamine intranasal, methylphenidate be avoided salmeterol and methylphenidate increase! ) phentermine increases effects of methylphenidate by enhancing GI absorption be opened and swallowed., and Concerta tiers and monitor Closely ( 1 ) esketamine intranasal, methylphenidate lunch ; `` preferred '' on... For each plan is initiated/dose increased, or decreased concentrations/effects if methylphenidate contraindicated... Nisoldipine by pharmacodynamic synergism exhibit concerta ritalin conversion chart solubility that may affect their systemic exposure efficacy! More likely w/thioridazine than other phenothiazines ) phentermine increases effects of iohexol by unspecified interaction.! Is not recommended 14 days following discontinuation concerta ritalin conversion chart an MAOI and also a! Drug is available at a middle level co-pay any time ) epinephrine and methylphenidate increase! Are based on current dose regimen and concerta ritalin conversion chart judgment receive more details and instructions access...

Why Is My Gypsy Tart Runny, Lillington, Nc Police Blotter, Debordieu Beach Club Dining, How To Make A Camaro Ss Faster, Talbingo Boat Hire, Articles C